Medtronic (MDT) Remains Committed to Covidien (COV) Deal, Says Deutsche Bank Citing Management
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
Jefferies Still Sees Covidien (COV)/Medtronic (MDT) Deal Getting Done
October 16, 2014 7:02 AM EDTJefferies analyst Raj Denhoy maintained a Buy rating and $75 price target on Medtronic, Inc. (NYSE: MDT) saying they still believe the Covidien plc (NYSE: COV) deal gets done.
"The news on ABBVs reconsideration of the Shire deal... More
Covidien (COV) Falls on Reports AbbVie Ready to Drop Shire Bid
October 15, 2014 1:11 PM EDTCovidien plc (NYSE: COV) dropped on reports AbbVie is close to dropping its bid for Shire due to tax law changes (more here). In June Medtronic (NYSE: MDT) announced that they have entered into a definitive agreement to acquire Covidien.
... MoreUPDATE: AbbVie (ABBV) Close to Dropping Shire (SHPG) Bid on Tax Law Changes - Bloomberg
October 15, 2014 12:58 PM EDT(Updated - October 15, 2014 1:03 PM EDT)
AbbVie (NYSE: ABBV) is close to dropping its bid for Shire (Nasdaq: SHPG) after talks with the U.S. Treasury Department and IRS, according to Bloomberg sources. AbbVie believes tax law... More
